ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

An Unlucky Streak? Doctors Analyze Errors As Another Cancer Center Offers Apology

June 30, 1995

Sanofi Responds to Criticism From Oncologists

November 8, 2012

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001